50 related articles for article (PubMed ID: 1349354)
1. GnRH-associated peptide (GAP) is present in the rat striatum and affects the synthesis and release of dopamine.
Gobert A; Guibert B; Lenoir V; Kerdelhue B; Leviel V
J Neurosci Res; 1992 Feb; 31(2):359-64. PubMed ID: 1349354
[TBL] [Abstract][Full Text] [Related]
2. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 Mar; 192(3):642-53. PubMed ID: 1120962
[TBL] [Abstract][Full Text] [Related]
3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
4. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
5. The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function.
Leviel V; Gobert A; Guibert B
Neuroscience; 1990; 39(2):305-12. PubMed ID: 1982344
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-methyldopa on dopamine synthesis and release in rat striatum in vitro.
Uretsky NJ; Chase GJ; Lorenzo AV
J Pharmacol Exp Ther; 1975 Apr; 193(1):73-87. PubMed ID: 237116
[TBL] [Abstract][Full Text] [Related]
7. The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release.
Olivier V; Gobert A; Guibert B; Leviel V
Neurochem Int; 1999 Dec; 35(6):431-8. PubMed ID: 10524710
[TBL] [Abstract][Full Text] [Related]
8. Acute stimulatory effect of estradiol on striatal dopamine synthesis.
Pasqualini C; Olivier V; Guibert B; Frain O; Leviel V
J Neurochem; 1995 Oct; 65(4):1651-7. PubMed ID: 7561861
[TBL] [Abstract][Full Text] [Related]
9. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
10. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei.
Chesselet MF; Reisine TD
J Neurosci; 1983 Jan; 3(1):232-6. PubMed ID: 6130131
[TBL] [Abstract][Full Text] [Related]
13. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
[TBL] [Abstract][Full Text] [Related]
15. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
17. Direct observation of dopamine compartmentation in striatal nerve terminal by 'in vivo' measurement of the specific activity of released dopamine.
Leviel V; Gobert A; Guibert B
Brain Res; 1989 Oct; 499(2):205-13. PubMed ID: 2804675
[TBL] [Abstract][Full Text] [Related]
18. Effects of phencyclidine on the release and synthesis of newly formed dopamine.
Vickroy TW; Johnson KM
Neuropharmacology; 1983 Jul; 22(7):839-42. PubMed ID: 6137782
[TBL] [Abstract][Full Text] [Related]
19. Involvement of intraterminal dopamine compartments in the amine release in the cat striatum.
Leviel V; Guibert B
Neurosci Lett; 1987 May; 76(2):197-202. PubMed ID: 3587753
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and release of dopamine in rat striatal slices: requirement for exogenous tyrosine in the medium.
Büyükuysal RL; Moğol E
Neurochem Res; 2000 Apr; 25(4):533-40. PubMed ID: 10823587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
